Multi-Regional Clinical Trials: The Latest Guidance from FDA
Planning and designing clinical trials conducted in multiple geographic or regulatory regions
Posts about
Regulatory Submissions (5)
Monthly FDA Guidance and Regulatory News Review - December 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Monthly FDA Guidance and Regulatory News Review - November 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Monthly FDA Guidance and Regulatory News Review-October 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Monthly FDA Guidance and Regulatory News Review-September 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Successful DMC Services for Complex Hematologic Cancer Trial
Learn how Veristat's expert biostatistics team worked with a longstanding global biopharma sponsor...
Understanding the Critical Role of Data Monitoring Committees in Clinical Trials
Learn how Veristat's expert teams develop and organize various independent Data Monitoring...
Monthly FDA Guidance and Regulatory News Review - August 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
FDA’s Draft Guidance for Data Monitoring Committees (DMCs)
How Veristat’s Proven DMC Expertise for Complex Trials Supports Patient Safety and Sponsor Success
Monthly FDA Guidance and Regulatory News Review - July 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...